Speaker Profile
M.D., Ph.D., Professor, UCSF
Biography
Mekhail Anwar, MD, PhD, physician-scientist and Professor in Radiation Oncology at UCSF and Electrical Engineering at UC Berkeley, is developing fundamentally new approaches to guide cancer therapy at the cellular level by creating technology platforms effectively placing the physician inside the patient. Key to these efforts is the introduction of integrated circuits (computer chips) to biological detection, moving beyond electrical interfaces to communicate with molecules and cells - the fundamental drivers of disease states.Building on his early work in chip-scale imagers to enhance surgical precision, supported by the DoD and NIH, he leads a ARPA-H project advancing his VISION imaging platform into the clinic. Supported by the NIHs New Innovator Award, he creates chip-scale implants that visualize real-time tumor responses to immunotherapy from within the tumor itself.He received his BA in Physics from UC Berkeley, graduating as the University Medalist (valedictorian), PhD in Electrical Engineering from MIT and MD residency from UCSF.
Talk
Guiding Cellular Scale Cancer Care using Integrated Circuits in-Vivo
The inability to visualize cancer at cellular scale in patients is a fundamental roadblock to treating cancer. We will discuss personalizing therapy through (1) guiding cancer surgery at the single cell level and (2) the development of new integrated circuit-based platforms for monitoring - and adapting - the real-time tissue response to immunotherapy.
Clinical Dx Showcase:
UCSF
UCSF and UCB provide a synergistic combination of medical and engineering innovation to enable us to create novel integrated circuits to fundamentally change how we treat cancer.
Session Abstract – PMWC 2025 Silicon Valley
The PMWC 2025 Data Applications in Clinical Diagnostics Showcase will provide a 15-30 minute time slot for selected organizations, including commercial companies, clinical testing labs, and medical research institutions, to present their latest advancements, insights, applications, and technologies to an audience of clinicians, leading investigators, academic institutions, pharma and biotech, investors, and potential clients. We will learn about new technologies and findings that promise expedited, cost-effective, and accurate clinical diagnosis for early disease detection, treatment decisions, and disease prevention.
- Clinical Dx/Oncology (including Liquid Biopsy)
- Clinical Dx/Cardio Vascular
- Clinical Dx/Neurodegenerative
